Full dose, daily sofosbuvir treatment in end-stage renal disease: tolerability & safety of largest ESRD patient cohort exposed to this drug

H.E. Nazario,Apurva A. Modi, M. Ndungu,R. Ramirez, L. Tujague, J.S. Weinstein

JOURNAL OF HEPATOLOGY(2017)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要